Prednisone Recruiting Phase 2 Trials for Recurrent Prostate Carcinoma / Stage IV Prostate Cancer / Metastatic Hormone Refractory Prostate Cancer Treatment

IndicationsStatusPurposePhase
RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02807805Abiraterone Acetate, Niclosamide, and Prednisone in Treating Patients With Hormone-Resistant Prostate Cancer
NCT03764540Docetaxel Versus Cabazitaxel Post Abiraterone or Enzalutamide